Immediate Impact
13 standout
Citing Papers
Current and future immunotherapeutic approaches in pancreatic cancer treatment
2024 Standout
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
2023 Standout
Works of Lara Longpre being referenced
Phase II trial of Pexa-Vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, followed by sorafenib in patients with advanced hepatocellular carcinoma (HCC).
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lara Longpre | 8 | 6 | 12 | 4 | 19 | ||
| Ryan Moslin | 6 | 6 | 7 | 3 | 21 | ||
| Nancy Wang | 7 | 9 | 10 | 4 | 26 | ||
| Yonina Bykov | 7 | 3 | 4 | 8 | 5 | 18 | |
| Longcheng Wang | 6 | 5 | 4 | 3 | 25 | ||
| Zhixiang Ren | 12 | 7 | 6 | 13 | 4 | 24 | |
| Sandra Karitzky | 8 | 6 | 14 | 4 | 18 | ||
| Kristin Kreider | 5 | 1 | 5 | 22 | 4 | 24 | |
| Katie Farmer | 8 | 5 | 4 | 2 | 15 | ||
| Cheng Cheng | 4 | 11 | 6 | 4 | 21 | ||
| Hannah Beer | 5 | 2 | 4 | 15 | 4 | 22 |
All Works
Loading papers...